PALISADE BIO INC (PALI) Stock Earnings Estimates
NASDAQ:PALI • US6963894026
1.6 USD
-0.03 (-1.84%)
At close: Feb 20, 2026
1.63 USD
+0.03 (+1.87%)
After Hours: 2/20/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 250K | -100.00% | 82.652M | 84.727M 2.51% | 344.76M 306.91% | 61.059M -82.29% | 167.62M 174.52% | 442.98M 164.28% | |||||
| EBITDA YoY % growth | -11.735M -10.88% | -15.308M -30.45% | -12.841M 16.12% | N/A -15.69% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -11.737M -9.94% | -15.311M -30.45% | -12.845M 16.11% | -15.642M -15.68% | -12.11M 18.50% | -40.419M -233.77% | -57.496M -42.25% | -82.918M -44.21% | -77.883M 6.07% | -23.561M 69.75% | -40.445M -71.66% | 45.415M 212.29% | 277.62M 511.30% | |
| Operating Margin | N/A | N/A | -5,138.00% | N/A | N/A | N/A | N/A | -100.32% | -91.92% | -6.83% | -66.24% | 27.09% | 62.67% | |
| EPS YoY % growth | N/A | -247.95 91.73% | -29.10 88.26% | -11.90 59.53% | -0.85 92.78% | -0.42 51.08% | -0.56 -35.47% | -0.37 34.84% | -0.31 15.28% | -0.04 86.07% | 0.10 323.53% | 0.52 431.58% | 1.76 241.58% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.09 93.97% | -0.04 91.68% | -0.06 90.15% | -0.09 77.36% | -0.14 -53.01% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.875M -14.57% | -6.088M -163.57% | -9.17M -222.56% | -15.735M -380.98% | -32.562M -740.38% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.38 83.62% | -0.28 | -0.10 | -35.80% |
| Q2 2025 Q2Q % growth | -0.58 82.53% | -0.57 | -0.01 | -1.42% |
| Q1 2025 Q2Q % growth | -0.47 89.76% | -0.71 | 0.24 | 34.17% |
| Q4 2024 Q2Q % growth | -1.55 76.02% | -2.03 | 0.48 | 23.66% |
| Q3 2024 Q2Q % growth | -2.32 64.85% | -3.42 | 1.10 | 32.15% |
| Q2 2024 Q2Q % growth | -3.32 58.24% | -2.99 | -0.33 | -11.13% |
| Q1 2024 Q2Q % growth | -4.59 43.33% | -4.90 | 0.31 | 6.25% |
| Q4 2023 Q2Q % growth | -6.45 -106.65% | -5.28 | -1.17 | -22.19% |
| Q3 2023 Q2Q % growth | -6.60 89.00% | -6.03 | -0.57 | -9.49% |
| Q2 2023 Q2Q % growth | -7.95 91.17% | -6.93 | -1.02 | -14.70% |
| Q1 2023 Q2Q % growth | -8.10 95.85% | -11.06 | 2.96 | 26.78% |
| Q4 2022 Q2Q % growth | 97.05 61.75% | -37.26 | 134.31 | 360.50% |
| Q3 2022 Q2Q % growth | -60.00 -119.05% | -61.20 | 1.20 | 1.96% |
| Q2 2022 Q2Q % growth | -90.00 -11,900.00% | -175.95 | 85.95 | 48.85% |
| Q1 2022 Q2Q % growth | -195.00 | -214.20 | 19.20 | 8.96% |
| Q4 2021 Q2Q % growth | 60.00 | -179.78 | 239.78 | 133.38% |
| Q3 2021 Q2Q % growth | 315.00 | -275.40 | 590.40 | 214.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 12.67% | 44.43% |
| Revenue | N/A | N/A | N/A | N/A |